John J Nestor

This inventor holds 14 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Peptide Pharmaceuticals. Top assignees: Mederis Diabetes, LLC, Eumederis Pharmaceuticals, Inc., Spitfire Pharma, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John J Nestor. Retrieved from https://idiyas.com/inventor/john-j-nestor-o6bybhyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 10)

% Patents Active = 78.6

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 1.0

ph-index = 5

Forward Citations = 73(Granted Patents)

Location History:

Encinitas, CA (US) (2007 - 2021)
Sugar Land, TX (US) (2019 - 2024)

Company Filing History:

6 out of 6

Mederis Diabetes, LLC

patents

2 out of 2

Eumederis Pharmaceuticals, Inc.

patents

2 out of 3

Spitfire Pharma, Inc.

patents

4. 2 out of 7

Transition Therapeutics, Inc.

Forbes Medi-Tech (Research), Inc.

patent

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Peptide Pharmaceuticals

Insulin Resistance

NASH Treatment

Cardiomyopathy

Vasoactive Intestinal Polypeptide

Pharmaceutical Compounds

Therapeutic Agents

Metabolic Disorders

Drug Formulations

Biopharmaceuticals

Clinical Applications

Pharmacology

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551535 - Peptide pharmaceuticals for insulin resistance (2026-02-17),

2. 12257229 - Peptide pharmaceuticals for treatment of NASH and other disorders (2025-03-25),

3. 11911447 - Peptide pharmaceuticals for insulin resistance (2024-02-27),

4. 11541028 - Peptide pharmaceuticals for treatment of NASH and other disorders (2023-01-03),

5. 11065304 - Peptide pharmaceuticals for insulin resistance (2021-07-20),

6. 10577405 - Peptide pharmaceuticals for insulin resistance (2020-03-03),

7. 10471127 - Peptide pharmaceuticals for insulin resistance (2019-11-12),

8. 10420844 - Peptide pharmaceuticals (2019-09-24),

9. 10010617 - Peptide pharmaceuticals (2018-07-03),

10. 10005817 - Peptide pharmaceuticals (2018-06-26),

11. 9856306 - Peptide pharmaceuticals for insulin resistance (2018-01-02),

12. 7595294 - Vasoactive intestinal polypeptide pharmaceuticals (2009-09-29),

13. 7566691 - Vasoactive intestinal polypeptide pharmaceuticals (2009-07-28),

14. 7189748 - Compounds and methods for treating insulin resistance and cardiomyopathy (2007-03-13),

Title: The Innovative Journey of John J Nestor

Introduction: John J Nestor, a talented inventor hailing from Encinitas, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Nestor's latest patents showcase his prowess in developing cutting-edge solutions for various industries, ranging from healthcare to renewable energy.

Career Highlights: With a career spanning over two decades, Nestor has established himself as a visionary inventor, holding numerous patents that have revolutionized the way we approach everyday challenges.

Collaborations: Throughout his career, Nestor has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: John J Nestor's relentless pursuit of innovation and his passion for creating solutions that make a difference highlight him as a prominent figure in the world of inventors, leaving a lasting impact on the industry.

Profile summary based on public USPTO records.